Blog

Opinion: How investors should play gene-therapy stocks – MarketWatch


MarketWatch

Opinion: How investors should play genetherapy stocks
MarketWatch
While traditional research is usually focused on unlocking a way to treat one condition, gene therapies such as Luxturna may be game changers because they are based on platforms that can be adapted and used to tackle multiple inherited disorders.

2017-09-05 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.